FDA NCTR On-Site Pathology Services

The U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR) is seeking a contractor to provide comprehensive on-site pathology services for animal research. The solicitation (75F40125R00059) will require a vendor capable of delivering extensive pathology support, including necropsy, histopathology, special staining, hematology, clinical chemistry, and specialized techniques such as teratology, reproductive toxicology, respiratory pathology, sperm analysis, and mammary whole mounts. The contract will be a Labor Hour (LH) type with a base period and up to four additional 1-year option periods. Anticipated release of the full solicitation is scheduled for April 30, 2025, with a 30-calendar-day submission window for potential contractors. While specific evaluation criteria are not detailed in the pre-solicitation notice, the contract aims to support NCTR's internationally recognized toxicological research activities that collaborate with FDA, other government agencies, industry, and academic institutions.

The procurement is classified under NAICS code 541990 (All Other Professional, Scientific, and Technical Services) with a small business size standard of $19.5 million, and will be conducted as a full and open competition, allowing responses from businesses of all sizes. No specific set-aside designations are currently indicated, which means all qualified businesses can compete for the contract. The precise award value is not explicitly stated in the pre-solicitation notice, but the comprehensive nature of the required services suggests a significant contract scope. The contract will support critical public health research through detailed pathological analysis and scientific investigation. The duration of services is expected to span the base period plus potential option years, providing a stable, multi-year engagement for the selected contractor.